Randomized, placebo- controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results

Circulation

Volumn 104, Issue 1, 2001, Pages 39-45

  Wojnicz, Romuald ^a   Nowalany Kozielska, Ewa ^a   Wojciechowska, Celina ^a   Glanowska, Grazyna ^a   Wilczewski, Przemysaw ^a   Niklewski, Tomasz ^a   Zembala, Marian ^a   Poloński, Lech ^a   Rozek, Marius M ^b   Wodniecki, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Cardiomyopathy; Heart failure; HLA antigens; Immunohistochemistry; Myocarditis

Indexed keywords

AMIODARONE; AZATHIOPRINE; CAPTOPRIL; FUROSEMIDE; METOCARD; METOPROLOL; PREDNISONE; SPIRONOLACTONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEART DILATATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0035800063     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.104.1.39     Document Type: Article

References (31)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
2. Myocarditis
3. The clinical course of idiopathic dilated cardiomyopathy: A population-based study
4. Idiopathic dilated cardiomyopathy
5. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
6. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future
7. Mechanisms of immune-mediated myocyte injury
8. Myocarditis: The Dallas criteria
9. Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy
10. "Borderline myocarditis": An indication for repeat endomyocardial biopsy
11. Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: A nonhistologic marker of myocarditis
12. Autoimmunity in myocarditis: Models and mechanisms
13. Novel organ-specific cardiac autoantibodies in dilated cardiomyopathy
14. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy
15. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy
16. Recently diagnosed idiopathic dilated dilated cardiomyopathy: Incidence of myocarditis and efficacy of prednisone therapy
17. A clinical trial of immunosuppressive therapy for myocarditis
18. Immunohistological diagnosis of myocarditis: Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury
19. Long-term outcomes of patients with biopsy-proved myocarditis: Comparison with idiopathic dilated cardiomyopathy
20. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy
21. Isolation, culture, and characterisation of MHC class II-positive microvascular endothelial cells from the human heart
22. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium: Cell adhesion molecule expression in human cardiac allografts
23. Abnormal expression of histocompatibility and mitochondrial antigens by cardiac tissue from patients with myocarditis and dilated cardiomyopathy
24. Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease
25. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against β2-adrenoceptor with positive chronotropic effect
26. Immunosuppressive treatment in autoreactive myocarditis: Results from a controlled trial
27. Endomyocardial biopsy in patients with unexplained congestive heart failure
28. Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis
29. Cell-mediated cytotoxicity in hears with dilated cardiomyopathy: Correlation with interstitial fibrosis and foci of activated T lymphocytes
30. Treatment of chronic myocarditis with corticosteroids
31. The role of myocarditis in end-stage dilated cardiomyopathy